Health Minister Yet to Decide on Prohibiting Sale of FDC
The Drug Controller General of India (DCGI) is still to take a proper decision on banning the controversial FDCs or approaching the court to vacate the interim stay granted by the High Court of Himachal Pradesh on the DCGI directive to file safety and efficacy data on FDC drugs approved by the State Licensing Authorities.
The latest sources convey that the Health Ministry indicated Government would not rush to a hasty decision as the matter was brought to the courts in numerous States and only interim stay was granted now.
It is also reported that according to DCGI order, if the manufacturers failed to submit the data before the deadline, these cogent FDCs would be regarded for being prohibited for manufacture and marketing in the country.
In conclusion the latest report conveys that the Haryana Pharmaceutical Manufacturers Association (HPMA) has professionally moved Punjab and Haryana High Court challenging the same order. Even the Punjab Drug Manufacturers Association also expediently joined as a party in the case.